Clinical Trials Directory

Trials / Completed

CompletedNCT06038812

Galectin Role in Periodontal Disease

Outcome of Non-surgical Periodontal Treatment on Gal-1 & Gal-3 GCF Levels in Periodontitis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Fayoum University · Academic / Other
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study aimed at exploring the effect of nonsurgical periodontal treatment on galectin 1 and 3 GCF levels in patients having gingivitis, periodontitis stage III compared to periodontally healthy individuals and if galectin-1 and -3 could serve as diagnostic markers and/or therapeutic targets for periodontitis, in addition to revealing their possible role in the periodontal disease. 45 systemically healthy participants were enrolled in this investigation, equally subdivided into three groups of 15 patients each: gingivitis, periodontitis (stage III) and control group with healthy gingiva. Probing depth, clinical attachment level, gingival and plaque index were registered. GCF levels of galectin-1 and -3 were evaluated in all included groups (before and after non-surgical treatment for periodontitis group) using enzyme linked immune-sorbent assay (ELISA) kit.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGCF sample collectioncollecting GCF from deepest sites by paper points
PROCEDUREnon-surgical periodontal treatmentperforming scaling and root planning using ultrasonic device and manual curettes

Timeline

Start date
2023-08-01
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2023-09-15
Last updated
2024-01-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06038812. Inclusion in this directory is not an endorsement.